HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yingying Guo Selected Research

Monoclonal Antibodies

1/2021Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies.
1/2020A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yingying Guo Research Topics

Disease

16Neoplasms (Cancer)
06/2022 - 03/2013
4Carcinogenesis
01/2022 - 06/2014
4Infections
01/2022 - 03/2015
4COVID-19
12/2021 - 01/2020
4Breast Neoplasms (Breast Cancer)
04/2021 - 02/2012
3Cardiomegaly (Heart Hypertrophy)
01/2022 - 01/2017
3Hepatocellular Carcinoma (Hepatoma)
11/2015 - 02/2015
2Hypoxia (Hypoxemia)
02/2022 - 01/2022
2Esophageal Neoplasms (Esophageal Cancer)
01/2022 - 01/2020
2Fibrosis (Cirrhosis)
10/2021 - 10/2021
2Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2021 - 01/2019
2Drug-Related Side Effects and Adverse Reactions
04/2021 - 01/2020
2Hypertension (High Blood Pressure)
01/2021 - 02/2015
2Alzheimer Disease (Alzheimer's Disease)
01/2020 - 03/2019
2Adenocarcinoma
04/2016 - 06/2014
2Osteoporosis
01/2016 - 07/2006
1Shock
10/2022
1Idiopathic Pulmonary Fibrosis
06/2022
1Gastroenteritis
01/2022
1Abdominal Obesity
01/2022
1Azoospermia
01/2022
1Chronic Disease (Chronic Diseases)
01/2022
1Hypertrophy
01/2022
1Esophageal Squamous Cell Carcinoma
01/2022
1Hyperlipoproteinemia Type IV (Type IV, Hyperlipoproteinemia)
01/2022
1Type III Amelogenesis Imperfecta
05/2021
1Weight Loss (Weight Reduction)
01/2021
1Obesity
01/2021
1Prostatic Neoplasms (Prostate Cancer)
12/2020
1Heart Failure
11/2020
1Aneuploidy (Aneuploid)
09/2020
1Necrosis
01/2020
1Triple Negative Breast Neoplasms
01/2020
1Pulmonary Arterial Hypertension
01/2020
1Asthma (Bronchial Asthma)
01/2020
1Disease Progression
01/2020

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
06/2022 - 11/2015
9Pharmaceutical PreparationsIBA
02/2022 - 07/2006
5EnzymesIBA
01/2020 - 07/2006
4Long Noncoding RNAIBA
06/2022 - 01/2019
4AntioxidantsIBA
01/2022 - 01/2018
3VaccinesIBA
01/2022 - 01/2012
3Messenger RNA (mRNA)IBA
10/2021 - 01/2020
2Biological ProductsIBA
01/2022 - 12/2020
2Indicators and Reagents (Reagents)IBA
01/2022 - 01/2021
2Bleomycin (Blenoxane)FDA LinkGeneric
10/2021 - 01/2019
2Therapeutic UsesIBA
04/2021 - 01/2020
2Doxorubicin (Adriamycin)FDA LinkGeneric
04/2021 - 01/2017
2LipidsIBA
01/2021 - 06/2017
2Monoclonal AntibodiesIBA
01/2021 - 01/2020
2LuciferasesIBA
12/2020 - 01/2020
2Cytochrome P-450 CYP2D6 (CYP2D6)IBA
01/2020 - 10/2015
2GinsenosidesIBA
01/2019 - 10/2012
2Mucin-1 (CA 15-3 Antigen)IBA
04/2016 - 11/2015
2Transforming Growth Factor beta (TGF-beta)IBA
03/2015 - 02/2015
2Glycoproteins (Glycoprotein)IBA
02/2015 - 06/2014
1SNARE Proteins (SNAREs)IBA
10/2022
1Immune Checkpoint InhibitorsIBA
06/2022
1Hemoglobins (Hemoglobin)IBA
02/2022
1diosmetinIBA
01/2022
1AntibodiesIBA
01/2022
1nitrosobenzylmethylamineIBA
01/2022
1Broadly Neutralizing AntibodiesIBA
01/2022
1Triglycerides (Triacylglycerol)IBA
01/2022
1astaxanthine (astaxanthin)IBA
01/2022
1CollagenIBA
10/2021
1Protein Isoforms (Isoforms)IBA
10/2021
1Nonsense Codon (Nonsense Mutation)IBA
05/2021
1Silicon Dioxide (Silica)FDA LinkGeneric
04/2021
1Hyaluronic Acid (Hyaluronan)IBA
04/2021
1Neutralizing AntibodiesIBA
01/2021
1SesquiterpenesIBA
12/2020
1LactonesIBA
12/2020
1oligomycin sensitivity-conferring protein (complex V)IBA
11/2020
1InterferonsIBA
10/2020
1CamptothecinIBA
09/2020
1lanabecestatIBA
01/2020
1Cytochrome P-450 CYP2C9IBA
01/2020
1sinigrinIBA
01/2020
1PhytochemicalsIBA
01/2020
1Rosuvastatin Calcium (Crestor)FDA Link
01/2020
1Cytochrome P-450 CYP3AIBA
01/2020
1Transforming Growth Factor-beta Type I ReceptorIBA
01/2020
1abemaciclibIBA
01/2020
1Angiotensin-Converting Enzyme 2IBA
01/2020
1Amyloid (Amyloid Fibrils)IBA
01/2020
1Cytochrome P-450 CYP1A2 (CYP1A2)IBA
01/2020
1MonocrotalineIBA
01/2020
1Caffeine (No Doz)FDA LinkGeneric
01/2020
1NF-kappa B (NF-kB)IBA
01/2020
1Warfarin (Coumadin)FDA LinkGeneric
01/2020
1Dextromethorphan (Racemethorphan)FDA LinkGeneric
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020

Therapy/Procedure

9Therapeutics
06/2022 - 02/2015
2Drug Therapy (Chemotherapy)
04/2021 - 01/2020
1Oncolytic Virotherapy
06/2022
1Chemoprevention
01/2022
1Tissue Transplantation
01/2022
1Photothermal Therapy
04/2021
1Combination Drug Therapy (Combination Chemotherapy)
01/2020